| scholarly article | Q13442814 |
| P356 | DOI | 10.1016/S0002-9343(02)01118-X |
| P698 | PubMed publication ID | 12079714 |
| P50 | author | Lindsey A. Criswell | Q67485118 |
| P2093 | author name string | Hongzhe Li | |
| Jean L Olson | |||
| Raymond F Lum | |||
| Victoria A Seligman | |||
| P2860 | cites work | Clinical characteristics and outcome of southern Chinese males with systemic lupus erythematosus | Q77794848 |
| Renal involvement in systemic lupus erythematosus. A study of 180 patients from a single center | Q77824770 | ||
| Nonparametric Estimation from Incomplete Observations | Q25938997 | ||
| The 1982 revised criteria for the classification of systemic lupus erythematosus | Q29547225 | ||
| Updating the American College of Rheumatology revised criteria for the classification of systemic lupus erythematosus | Q29614922 | ||
| Lupus erythematosus in the 1980s: a survey of 570 patients | Q33384712 | ||
| Systemic Lupus Erythematosus in Males | Q33476416 | ||
| Systemic lupus erythematosus: emerging concepts. Part 1: Renal, neuropsychiatric, cardiovascular, pulmonary, and hematologic disease | Q33489732 | ||
| Systemic lupus erythematosus. III. Observations on clinical renal involvement and follow up of renal function: Dutch experience with 110 patients studied prospectively. | Q33562068 | ||
| Racial group, socioeconomic status, and the development of persistent proteinuria in systemic lupus erythematosus | Q35549094 | ||
| Systemic lupus erythematosus in three ethnic groups: III. A comparison of characteristics early in the natural history of the LUMINA cohort. LUpus in MInority populations: NAture vs. Nurture | Q46430510 | ||
| Morbidity of systemic lupus erythematosus: role of race and socioeconomic status | Q46891297 | ||
| P433 | issue | 9 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | lupus nephritis | Q1621830 |
| P304 | page(s) | 726-729 | |
| P577 | publication date | 2002-06-01 | |
| P1433 | published in | American Journal of Medicine | Q2842959 |
| P1476 | title | Demographic differences in the development of lupus nephritis: a retrospective analysis | |
| P478 | volume | 112 |
| Q37621413 | A gene network regulated by the transcription factor VGLL3 as a promoter of sex-biased autoimmune diseases |
| Q35223839 | A retrospective analysis of clinical presentation of lupus nephritis |
| Q37896370 | Age- and gender-related long-term renal outcome in patients with lupus nephritis. |
| Q34983538 | Analysis of gender differences in genetic risk: association of TNFAIP3 polymorphism with male childhood-onset systemic lupus erythematosus in the Japanese population |
| Q34184151 | Anti-malarials exert a protective effect while Mestizo patients are at increased risk of developing SLE renal disease: data from a Latin-American cohort |
| Q38070903 | Asian ethnicity in systemic lupus erythematosus: an Australian perspective. |
| Q51048045 | Assessment of a lupus nephritis cohort over a 30-year period. |
| Q35496923 | Association analyses confirm five susceptibility loci for systemic lupus erythematosus in the Han Chinese population |
| Q40130874 | Association of Asian ethnicity with disease activity in SLE: an observational study from the Monash Lupus Clinic |
| Q50062067 | Association of the CD11b rs1143679 polymorphism with systemic lupus erythematosus in the Han Chinese population |
| Q52620149 | CD11b Activity Modulates Pathogenesis of Lupus Nephritis. |
| Q87393398 | Chapter 12: Lupus nephritis |
| Q36663933 | Characterization of Patients With Lupus Nephritis Included in a Large Cohort From the Spanish Society of Rheumatology Registry of Patients With Systemic Lupus Erythematosus (RELESSER). |
| Q36193933 | Clinical and laboratory predictors of distinct histopathogical features of lupus nephritis |
| Q36752458 | Clinical features, epidemiology, and short-term outcomes of proliferative lupus nephritis in Eastern India |
| Q37857737 | Clinicopathological insights into lupus glomerulonephritis in Japanese and Asians |
| Q91803887 | Delayed lupus nephritis in the course of systemic lupus erythematosus is associated with a poorer treatment response: a multicentre, retrospective cohort study in Japan |
| Q51173136 | Efficacy and toxicity of treatments for nephritis in a series of consecutive lupus patients. |
| Q35216317 | Ethnic disparities in patients with systemic lupus erythematosus |
| Q43752384 | European ancestry decreases the risk of early onset, severe lupus nephritis in a single center, multiethnic pediatric lupus inception cohort |
| Q37398821 | European genetic ancestry is associated with a decreased risk of lupus nephritis |
| Q37335908 | European population substructure is associated with mucocutaneous manifestations and autoantibody production in systemic lupus erythematosus |
| Q52897553 | Genetics of human lupus nephritis. |
| Q33578262 | Geographical distribution, a risk factor for the incidence of lupus nephritis in China |
| Q37183957 | ITGAM is associated with disease susceptibility and renal nephritis of systemic lupus erythematosus in Hong Kong Chinese and Thai |
| Q54365434 | Immunosuppressive treatment for pure membranous lupus nephropathy in a Hispanic population. |
| Q36360777 | Impact of genetic ancestry and sociodemographic status on the clinical expression of systemic lupus erythematosus in American Indian-European populations |
| Q37974647 | Impact of glomerular kidney diseases on the clearance of drugs |
| Q50598390 | Incidence and disease severity of anti-neutrophil cytoplasmic antibody-associated nephritis are higher than in lupus nephritis in Sweden. |
| Q37462538 | Influence of race/ethnicity on response to lupus nephritis treatment: the ALMS study |
| Q53089425 | Long-term outcome in Japanese patients with lupus nephritis. |
| Q26740487 | Lupus Nephritis in Asia: Clinical Features and Management |
| Q95592748 | Lupus nephritis |
| Q37834473 | Lupus nephritis in Colombians: contrasts and comparisons with other populations |
| Q38446941 | Lupus nephritis management guidelines compared |
| Q35553102 | Lupus nephritis: current issues |
| Q22000837 | Lupus nephritis: current update |
| Q90577592 | Lupus patient decisions about clinical trial participation: a qualitative evaluation of perceptions, facilitators and barriers |
| Q33756295 | MMP2 and MMP9 associate with crescentic glomerulonephritis |
| Q37800295 | Major lupus organ involvement: severe lupus nephritis |
| Q26991887 | Mesangial cell-specific antibodies are central to the pathogenesis of lupus nephritis |
| Q30655475 | Mestizos with systemic lupus erythematosus develop renal disease early while antimalarials retard its appearance: data from a Latin American cohort |
| Q46592474 | Outcomes in African Americans and Hispanics with lupus nephritis. |
| Q35596715 | Phenotypic associations of genetic susceptibility loci in systemic lupus erythematosus |
| Q34947727 | Population differences in SLE susceptibility genes: STAT4 and BLK, but not PXK, are associated with systemic lupus erythematosus in Hong Kong Chinese |
| Q47100353 | Predictors of incident proteinuria among patients with SLE. |
| Q36054839 | Prognostic factors in lupus nephritis |
| Q33945242 | Quality of care for incident lupus nephritis among Medicaid beneficiaries in the United States |
| Q64124003 | Racial/Ethnic Differences in Prevalence of and Time to Onset of SLE Manifestations: The California Lupus Surveillance Project (CLSP) |
| Q35626485 | Random spot urine protein/creatinine ratio: a reliable method for monitoring lupus nephritis? |
| Q37146440 | Randomized, controlled trial of prednisone, cyclophosphamide, and cyclosporine in lupus membranous nephropathy |
| Q57945954 | References |
| Q36697845 | Renal Biopsy: A much needed tool in patients with Systemic Lupus Erythematosis (SLE). |
| Q53242137 | Renal damage in systemic lupus erythematosus: a comparative analysis of different age groups. |
| Q46100560 | Renin-angiotensin system gene polymorphisms predict the progression to renal insufficiency among Asians with lupus nephritis |
| Q39069721 | Retrospective review of lupus nephritis in a New Zealand multi-ethnic cohort |
| Q37678723 | Review: Lupus nephritis: pathologic features, epidemiology and a guide to therapeutic decisions. |
| Q38222239 | Rheumatological diseases and kidneys: a nephrologist's perspective |
| Q38479339 | Risk factors for renal disease in systemic lupus erythematosus and their clinical implications |
| Q37800307 | Stem cell transplantation: progress in Asia |
| Q37754835 | Systemic lupus erythematosus and ethnicity: nature versus nurture or nature and nurture? |
| Q39053118 | Systemic lupus erythematosus biomarkers: the challenging quest |
| Q37587317 | TAC-TIC use of tacrolimus-based regimens in lupus nephritis |
| Q85360834 | The Contribution of Meta-Analysis of Genome-Wide Association Studies in Investigating the Genetic Susceptibility to Lupus |
| Q37800303 | The economic burden of systemic lupus erythematosus in Asia: the current state |
| Q33701388 | The lupus family registry and repository |
| Q37822658 | Treatment of proliferative lupus nephritis: a slowly changing landscape |
| Q33632025 | US patients of Hispanic and African ancestry develop lupus nephritis early in the disease course: data from LUMINA, a multiethnic US cohort (LUMINA LXXIV). |
| Q37638666 | Urinary Albumin Levels are Independently Associated with Renal Lesion Severity in Patients with Lupus Nephritis and Little or No Proteinuria |
| Q47599534 | Urinary neutrophil gelatinase-associated lipocalin and monocyte chemoattractant protein 1 as biomarkers for lupus nephritis in Colombian SLE patients |
| Q48129331 | Very delayed lupus nephritis: a report of three cases and literature review. |
Search more.